Prognostic methylation markers for overall survival in cytogenetically normal AML patients treated on SWOG trials

BACKGROUND: Aberrant DNA methylation is known to occur in acute myeloid leukemia (AML), while methylation signatures and prognostic markers have been proposed. This study aimed to evaluate all CpG sites of the genome and identify prognostic methylation markers for overall survival in AML patients wi...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cancer
Main Authors: Qu, Xiaoyu, Othus, Megan, Davison, Jerry, Wu, Yu, Yan, Liying, Meshinchi, Soheil, Ostronoff, Fabiana, Estey, Elihu, Radich, Jerry, Erba, Harry, Appelbaum, Frederick R., Fang, Min
Format: Artigo
Sprog:Inglês
Udgivet: 2017
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5705230/
https://ncbi.nlm.nih.gov/pubmed/28222251
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30626
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker